Literature DB >> 7594477

Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.

A B Vogt1, L J Stern, C Amshoff, B Dobberstein, G J Hämmerling, H Kropshofer.   

Abstract

In the endoplasmic reticulum, MHC class II alpha beta dimers associate with the trimeric invariant chain (li), generating a nine-subunit (alpha beta li)3 complex. In the presence of li, the peptide binding groove is blocked, so that loading with self or antigenic peptides can only occur after proteolytic removal of li in specialized post-Golgi compartments. The class II-associated invariant chain peptide region of li (about residues 81-104) is known to mediate binding to class II molecules and blockade of the groove, but this does not exclude additional contact sites for li. Using a set of overlapping li peptides and recombinant soluble li, we demonstrate here that a large segment of li encompassing approximately residues 71 to 128 interacts with HLA-DR molecules. The N- and C-terminal regions of this li segment appear to bind outside the peptide groove to the contact area for the staphylococcal superantigen Staphylococcus aureus enterotoxin B on the alpha 1 domain. The core region of this segment (residues 95-108) prevents binding of antigenic peptides, probably by interaction with the peptide groove. Occupation of the groove with antigenic peptides abolishes binding not only of the core region, but also that of those li peptides that bind outside the groove. These findings suggest the existence of distinct conformational states of class II molecules, with li binding preferentially to one form.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594477

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Role of the major histocompatibility complex class II transmembrane region in antigen presentation and intracellular trafficking.

Authors:  Yelena A Barabanova; Hee-Kap Kang; Jinjong Myoung; Bongsu Kang; Gail A Bishop; Byung S Kim
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

2.  Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM.

Authors:  A B Vogt; H Kropshofer; G Moldenhauer; G J Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 3.  Protein sorting within the MHC class II antigen-processing pathway.

Authors:  M S Marks
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

Review 4.  Selection of the MHC class II-associated peptide repertoire by HLA-DM.

Authors:  S O Arndt; A B Vogt; G J Hämmerling; H Kropshofer
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

5.  A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.

Authors:  H Kropshofer; A B Vogt; C Thery; E A Armandola; B C Li; G Moldenhauer; S Amigorena; G J Hämmerling
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

6.  Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.

Authors:  P Stumptner; P Benaroch
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

7.  Editing of the HLA-DR-peptide repertoire by HLA-DM.

Authors:  H Kropshofer; A B Vogt; G Moldenhauer; J Hammer; J S Blum; G J Hämmerling
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

8.  Functional HLA-DM on the surface of B cells and immature dendritic cells.

Authors:  S O Arndt; A B Vogt; S Markovic-Plese; R Martin; G Moldenhauer; A Wölpl; Y Sun; D Schadendorf; G J Hämmerling; H Kropshofer
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

9.  Boosting immune response with the invariant chain segments via association with non-peptide binding region of major histocompatibility complex class II molecules.

Authors:  Fangfang Chen; Fantao Meng; Ling Pan; Fazhi Xu; Xuelan Liu; Weiyi Yu
Journal:  BMC Immunol       Date:  2012-09-27       Impact factor: 3.615

Review 10.  Partnering for the major histocompatibility complex class II and antigenic determinant requires flexibility and chaperons.

Authors:  Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2021-06-17       Impact factor: 7.268

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.